You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for NORWICH PHARMACEUTICALS, INC. v. BECERRA (D.D.C. 2023)


✉ Email this page to a colleague

« Back to Dashboard


NORWICH PHARMACEUTICALS, INC. v. BECERRA (D.D.C. 2023)

Small Molecule Drugs cited in NORWICH PHARMACEUTICALS, INC. v. BECERRA
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for NORWICH PHARMACEUTICALS, INC. v. BECERRA (D.D.C. 2023)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2023-06-05 1 Exhibit 1 (the 9'828 patent) July 24, 2029 10,314,828 (the 4'828 patent) July 24, 2029 …550 mg, is subject to periods of patent protection. The following patents and expiration dates are currently… U.S. Patent Number Expiration Date 7,045,620 (the '620 patent) June…7,612,199 (the '199 patent) June 19, 2024 7,902,206 (the '206 patent) June 19, 2024…7,906,542 (the '542 patent) June 1, 2025 7,915,275 (the '275 patent) February 23, External link to document
2023-06-12 12 Exhibit Complaint (last visited Jun. 4, 2023). 10 U.S. Patent Nos. 10,314,828; 10,335,397; 10,456,384; 7,045,620; 7,612,199… “Asserted HE Patents” refers to claim 8 of U.S. Patent No. 8,642,573 (the “’573 Patent”), claim 6 of …of U.S. Patent No. 9,421,195 (the “’195 Patent”), and claims 11-12 of U.S. Patent No. 10,335,397 (the “…claims from three asserted method of use patents (“the HE Patents”), and that Norwich’s Original ANDA should…Amended ANDA contain a Paragraph IV patent certification to any patent held to have been infringed under External link to document
2023-06-05 4 Exhibit 1 to Landmon Declaration “’195 Patent”); 9,629,828 (the “’9,828 Patent”); 10,314,828 (the “’4,828 Patent”); 10,335,397 (the “… United States Patent Nos. 7,045,620 (the “’620 Patent”); 7,612,199 (the “’199 Patent”); 7,902,206 (… (the “’206 Patent”); 7,906,542 (the “’542 Patent”); 7,915,275 (the “’275 Patent”); 8,158,644 (the “… “’644 Patent”); 8,158,781 (the “’781 Patent”); 8,193,196 (the “’196 Patent”); 8,309,569 (the “’569 …569 Patent”); 8,518,949 (the “’949 Patent”); 8,642,573 (the “’573 Patent”); 8,741,904 (the “’904 Patent External link to document
2023-08-16 51 Redacted Document (the 9'828 patent) July 24, 2029 10,314,828 (the 4'828 patent) July 24, 2029 … “Asserted HE Patents” refers to claim 8 of U.S. Patent No. 8,642,573 (the “’573 Patent”), claim 6 of …of U.S. Patent No. 9,421,195 (the “’195 Patent”), and claims 11-12 of U.S. Patent No. 10,335,397 (the “…Asserted HE Patents because, as shown below, a claim for patent infringement of the Asserted HE Patents under…of claim 8 of U.S. Patent No. 8,642,573 (the “’573 Patent”), claim 6 of U.S. Patent No. 9,421,195 (the External link to document
2023-10-09 61 Exhibit Stipulation and Order in re Salix et al. v. Norwich (20-430, D. Del.) the “’195 Patent”); 9,629,828 (the “’9,828 Patent”); 10,314,828 (the “’4,828 Patent”); 10,335,397 (the…’644 Patent; the ’781 Patent; the ’196 Patent; the ’949 Patent; the ’904 Patent; the ’017 Patent; the…452 Patent; the ’231 Patent; the ’252 Patent; the ’398 Patent; the ’968 Patent; the ’9,828 Patent; the…the ’620 patent; the ’542 Patent; the ’275 Patent; ’644 Patent; the ’781 Patent; the ’196 Patent; the ’…’949 Patent; the ’904 Patent; the ’017 Patent; the ’452 Patent; the ’231 Patent; the ’252 Patent; the External link to document
2023-10-10 62 Exhibit Stipulation and [Proposed] Order in re Salix Pharmaceuticals, Ltd., et a the “’195 Patent”); 9,629,828 (the “’9,828 Patent”); 10,314,828 (the “’4,828 Patent”); 10,335,397 (the…’644 Patent; the ’781 Patent; the ’196 Patent; the ’949 Patent; the ’904 Patent; the ’017 Patent; the…452 Patent; the ’231 Patent; the ’252 Patent; the ’398 Patent; the ’968 Patent; the ’9,828 Patent; the…the ’620 patent; the ’542 Patent; the ’275 Patent; ’644 Patent; the ’781 Patent; the ’196 Patent; the ’…’949 Patent; the ’904 Patent; the ’017 Patent; the ’452 Patent; the ’231 Patent; the ’252 Patent; the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.